Skip to content

    Melanoma/Skin Cancer Health Center

    Font Size

    Melanoma Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Stage II Melanoma Treatment

    Standard Treatment Options for Stage II Melanoma

    Standard treatment options for stage II melanoma include the following:

    Recommended Related to Melanoma/Skin Cancer

    Should I Consider a Clinical Trial for Metastatic Melanoma?

    It's natural to want the very latest treatments when you have a serious health condition like metastatic melanoma. One way to get those cutting-edge drugs is to sign up for a clinical trial. Before you enroll, you'll want to learn all you can about the study, what's being tested, and the risks and benefits. Work with your doctor to get that information and make sure the trial is a good fit for you. But first, get to know what's involved.

    Read the Should I Consider a Clinical Trial for Metastatic Melanoma? article > >

    1. Excision with or without lymph node management.


    For melanomas with a thickness between 2 mm and 4 mm, surgical margins need to be 2 cm to 3 cm or smaller.

    Few data are available to guide treatment in patients with melanomas thicker than 4 mm; however, most guidelines recommend margins of 3 cm whenever anatomically possible.

    Depending on the location of the melanoma, most patients can have the excision performed on an outpatient basis.

    Evidence (excision):

    1. The Intergroup Melanoma Surgical Trial Task 2b compared 2-cm versus 4-cm margins for patients with melanomas that were 1 mm to 4 mm thick.[1]
      • With a median follow-up of more than 10 years, no significant difference in local recurrence or survival was observed between the two groups.
      • The reduction in margins from 4 cm to 2 cm was associated with the following:
        • A statistically significant reduction in the need for skin grafting (from 46% to 11%; P < .001).
        • A reduction in the length of the hospital stay.
    2. A study conducted in the United Kingdom randomly assigned patients with melanomas thicker than 2 mm to undergo excision with either 1-cm or 3-cm margins.[2]
      • Patients treated with excision with 1-cm margins had higher rates of local regional recurrence (hazard ratio [HR], 1.26; 95% confidence interval [CI], 1.00-1.59; P = .05).
      • No difference in survival was seen (HR, 1.24; 95% CI, 0.96-1.61; P = .1).
      • This study suggests that 1-cm margins may not be adequate for patients with melanomas thicker than 2 mm.

    Lymph Node Management

    Lymphatic mapping and sentinel lymph node biopsy (SLNB)

    Lymphatic mapping and SLNB have been used to assess the presence of occult metastasis in the regional lymph nodes of patients with stage II disease, potentially identifying individuals who may be spared the morbidity of regional lymph node dissections (LNDs) and individuals who may benefit from adjuvant therapy.[3,4,5,6,7]

    To ensure accurate identification of the sentinel lymph node (SLN), lymphatic mapping and removal of the SLN should precede wide excision of the primary melanoma.

    1 | 2 | 3 | 4
    1 | 2 | 3 | 4
    Next Article:

    Today on WebMD

    Malignant melanoma
    How to spot it early.
    Woman checking out tan lines
    There’s a dark side to that strive for beauty.
    sauteed cherry tomatoes
    Fight cancer one plate at a time.
    Lung cancer xray
    See it in pictures, plus read the facts.
    12 Ways to Protect Your Skin from Melanoma
    precancerous lesions slideshow
    Do You Know Your Melanoma ABCs
    15 Cancer Symptoms Men Ignore
    screening tests for men
    Vitamin D
    Is That Mole Skin Cancer
    Brilliant sun rays